Boston Area Anticoagulation Trial for Atrial Fibrillation (BAATAF)

Completed

Phase 3 Results

Results

There were 15 definite ischemic strokes in the control group and 2 in the warfarin group which corresponds to an 86% reduction in risk of stroke in warfarin group.